Biography

Myriam Briki obtained her BSc from the University of Lausanne after spending her final year at Uppsala University (Sweden), where she was able to focus mainly on toxicological sciences. As a result, she chose to specialize in pharmacology and toxicology during her MSc back in Lausanne. 
She is now doing her PhD on the development of population pharmacokinetics (pop-PK) meta-models for conventional cytotoxic chemotherapies. Once developped and validated, these models will allow to predict the evolution of the plasma concentration of the drugs for patients undergoing chemotherapy in order to adjust their dosage to reach optimal therapeutic exposure.
Her thesis is part of a multi-disciplinary project (PhD thesis of Mrs. Francesca Rodino and Mrs. Lin Du, EPFL) in which her models will be able to make Bayesian predictions based on drug plasma concentrations measured by biosensors, all in a single point-of-care device for precision medicine at the patient's bedside.